All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
EquityEquity - Follow-ons and Rights issues

Bayer launches jumbo rights issue as Monsanto deal closes

Werner_Bauman_PA_230x150

Bayer, the German life sciences company, this week unveiled the terms for a €6bn rights issue, after its acquisition of Monsanto, the US agrochemical and biotech company, cleared its final regulatory hurdles last week.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree